To further investigate the correlation between CREB5 expression and HNSCC cisplatin resistance, we used real-time PCR to quantify CREB5 mRNA levels in the extended HNSCC cohort. The gene discussed is CREB5; the disease is head and neck squamous cell carcinoma.